BSR Insight | Improving Partnerships to Solve Global Health Challenges
About the Author(s)
Mark Little, Director, Healthcare, Advisory Services
Publication Date
September 11, 2012
Share
BSR's new report on global health partnerships—an evaluation of 220 programs in more than 160 countries—reveals the challenges and success factors in partnerships between the pharmaceutical industry and NGOs, governments, and academia.
The report—for which BSR surveyed 20 pharmaceutical companies and interviewed experts from organizations including the World Health Organization, TB Alliance, GAVI Alliance, and the Global Fund—assessed the impact of partnerships formed around four health challenge areas: availability of treatment, health system infrastructure, research and development, and awareness/prevention.
The report identifies two main challenges:
- Because most partnerships involve one company, they do not fully benefit from the collective expertise that would come from having multiple companies involved.
- Until now, there has not been a uniform means of tracking outcomes and measuring the impact of these partnerships.
The report also lists critical success factors for global health partnerships:
- Adoption of an approach based on health needs
- Emphasis on broad-based, multicompany partnerships
- Alignment of existing and future partnerships to maximize shared resources and expertise
- Emphasis on existing country systems and local ownership
- Implementation of tracking and measurement programs to evaluate impact
About the Author(s)
Mark Little, Director, Healthcare, Advisory Services
Mark leads BSR's global healthcare practice, helping pharmaceutical, biotech, and medical device companies implement robust sustainability practices... Read more →
Share Your Thoughts
Please note, all comments are subject to moderation.